The 2009 edition of this incomparable CNS overview is comprised of two major components:
1) MAP: Mergers/Acquisitions/Partnering: With 2009 has come an increased focus upon seeking partners and allies in the service of both synergy and survival. Our updated evaluation covers Big Pharma licensing attributes and trends, with an assessment of how the current economic climate has led to alterations in BP behavior and leverage. Each major pharma company is evaluated, and the review provides a database covering partnership history, including financial terms. This review has been assembled from interviews with professionals on both sides of the large and small pharma divide, as well our evaluations of the licensing performance over time of each company. There is no other review of the Business Development and Licensing practices of the major pharmaceutical companies in the US and Europe with this level of detail and candor.
The M&A landscape is covered in depth for the first time, including rosters of the most promising M&A candidates within the CNS area. For small and midsize companies thinking about strategy and fit, this information is indispensable.
2) The second section of CNS 2009 compiles NI Research's comprehensive reviews of all major psychiatric and neurological indications, and the therapeutics programs under development. All reviews will be fully updated and revised. This database provides strategic planners and Business Development professionals with a complete review of the neuro and psychopharmaceutical universe of therapies in development, in a single searchable pdf. There is nothing else like CNS 2009: Disorders/Therapeutics, at any price.
Disorders covered in CNS 2009:Disorders/Therapeutics:
Addiction
Alertness/EDS
Alzheimer’s
Amyotrophic Lateral Sclerosis (ALS)
Anxiety
Attention Deficit Disorder (ADHD)
Bipolar Disorder
Depression
Epilepsy
Huntington’s
Insomnia
Memory Disorders (MCI/AAMI)
Migraine
Multiple Sclerosis (MS)
Neuropathic Pain
Nociceptive Pain
Parkinson’s
Schizophrenia
Spinal Cord Injury
Stroke
Traumatic Brain Injury (TBI)
|
